(-0.46%) 5 048.42 points
(-0.98%) 38 086 points
(-0.64%) 15 612 points
(0.23%) $83.76
(-4.58%) $1.563
(0.07%) $2 344.10
(0.15%) $27.40
(0.84%) $928.20
(0.09%) $0.933
(0.15%) $10.97
(0.09%) $0.800
(0.02%) $92.18
Live Chart Being Loaded With Signals
Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development for the treatment of solid tumors, such as melanoma, esophageal and gastroesophageal junction, sarcoma, and rectal and ovarian cancers in combination with immunotherapy, chemotherapy, radiation therapy, and cancer vaccines; and APX601, a humanized antagonist antibody that is in Phase I/II clinical trial for the treatment of multiple tumor indications, as well as APX801, an NK cell engager to activate natural killer cells to killing of tumor cells...
Stats | |
---|---|
Today's Volume | 94 426.00 |
Average Volume | 262 332 |
Market Cap | 9.57M |
EPS | $0 ( 2023-11-21 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.225 |
ATR14 | $0.0390 (10.13%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-08-23 | Zabrowksi Dan | Sell | 100 000 | Stock Option (right to buy) |
2023-08-23 | Wertheimer Samuel P | Sell | 146 383 | Common Stock |
2023-08-23 | Wertheimer Samuel P | Sell | 100 000 | Stock Option (right to buy) |
2023-08-23 | Wertheimer Samuel P | Sell | 12 383 | Warrants (right to buy) |
2023-08-23 | Wertheimer Samuel P | Sell | 1 845 | Warrants (right to buy) |
INSIDER POWER |
---|
-59.89 |
Last 97 transactions |
Buy: 2 466 920 | Sell: 6 182 886 |
Volume Correlation
Apexigen, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Apexigen, Inc. Correlation - Currency/Commodity
Apexigen, Inc. Financials
Annual | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-1.590 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.240 |
Q1 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.240 |
Q4 | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-330.41 |
Financial Reports:
No articles found.
Apexigen, Inc.
Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development for the treatment of solid tumors, such as melanoma, esophageal and gastroesophageal junction, sarcoma, and rectal and ovarian cancers in combination with immunotherapy, chemotherapy, radiation therapy, and cancer vaccines; and APX601, a humanized antagonist antibody that is in Phase I/II clinical trial for the treatment of multiple tumor indications, as well as APX801, an NK cell engager to activate natural killer cells to killing of tumor cells. The company was founded in 2010 and is based in San Carlos, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators